Free Trial

Tenet Healthcare Co. (NYSE:THC) Shares Purchased by Jump Financial LLC

Tenet Healthcare logo with Medical background

Jump Financial LLC boosted its position in Tenet Healthcare Co. (NYSE:THC - Free Report) by 605.9% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 83,055 shares of the company's stock after purchasing an additional 71,289 shares during the quarter. Jump Financial LLC owned about 0.09% of Tenet Healthcare worth $10,484,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in THC. Norges Bank purchased a new position in Tenet Healthcare in the 4th quarter worth approximately $190,819,000. Wealthfront Advisers LLC acquired a new position in Tenet Healthcare during the fourth quarter worth $69,059,000. Raymond James Financial Inc. acquired a new stake in shares of Tenet Healthcare in the 4th quarter worth $49,001,000. Renaissance Technologies LLC raised its holdings in shares of Tenet Healthcare by 579.2% during the 4th quarter. Renaissance Technologies LLC now owns 438,563 shares of the company's stock worth $55,360,000 after acquiring an additional 373,988 shares during the period. Finally, Bridgewater Associates LP grew its holdings in shares of Tenet Healthcare by 225.4% in the fourth quarter. Bridgewater Associates LP now owns 407,194 shares of the company's stock valued at $51,400,000 after purchasing an additional 282,071 shares during the period. Institutional investors and hedge funds own 95.44% of the company's stock.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on THC. Morgan Stanley assumed coverage on shares of Tenet Healthcare in a research report on Wednesday, March 26th. They set an "overweight" rating and a $165.00 price target on the stock. Guggenheim began coverage on shares of Tenet Healthcare in a research report on Wednesday, April 9th. They issued a "buy" rating and a $165.00 target price on the stock. Barclays dropped their target price on shares of Tenet Healthcare from $190.00 to $161.00 and set an "overweight" rating for the company in a report on Thursday, February 13th. Baird R W lowered Tenet Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 15th. Finally, KeyCorp reduced their target price on shares of Tenet Healthcare from $200.00 to $185.00 and set an "overweight" rating on the stock in a report on Tuesday, January 7th. Five analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $165.44.

View Our Latest Report on Tenet Healthcare

Insiders Place Their Bets

In other Tenet Healthcare news, Director J Robert Kerrey sold 9,525 shares of the stock in a transaction dated Tuesday, March 11th. The shares were sold at an average price of $125.43, for a total value of $1,194,720.75. Following the completion of the transaction, the director now directly owns 27,378 shares of the company's stock, valued at approximately $3,434,022.54. This trade represents a 25.81 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 0.93% of the company's stock.

Tenet Healthcare Stock Performance

NYSE THC traded up $1.03 on Friday, reaching $121.47. The stock had a trading volume of 968,650 shares, compared to its average volume of 1,511,401. The stock has a market cap of $11.46 billion, a P/E ratio of 3.77, a price-to-earnings-growth ratio of 1.02 and a beta of 1.77. The business's 50-day moving average price is $127.88 and its 200 day moving average price is $138.14. The company has a debt-to-equity ratio of 2.25, a quick ratio of 1.70 and a current ratio of 1.78. Tenet Healthcare Co. has a 12-month low of $90.03 and a 12-month high of $171.20.

Tenet Healthcare (NYSE:THC - Get Free Report) last posted its quarterly earnings data on Wednesday, February 12th. The company reported $3.44 EPS for the quarter, beating the consensus estimate of $2.95 by $0.49. Tenet Healthcare had a return on equity of 21.88% and a net margin of 15.48%. As a group, equities analysts expect that Tenet Healthcare Co. will post 12.24 earnings per share for the current year.

Tenet Healthcare Profile

(Free Report)

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.

Featured Stories

Institutional Ownership by Quarter for Tenet Healthcare (NYSE:THC)

Should You Invest $1,000 in Tenet Healthcare Right Now?

Before you consider Tenet Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tenet Healthcare wasn't on the list.

While Tenet Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Tech Stocks to Buy Now—And 3 You’ll Regret Keeping
After Stellar Earnings, Is TSMC the Next Chip Leader?
Palantir’s Big Week Reveals a Rare Growth Story in a Shaky Market

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines